» Articles » PMID: 8097114

Central D2-dopamine Receptor Occupancy in Relation to Antipsychotic Drug Effects: a Double-blind PET Study of Schizophrenic Patients

Overview
Journal Biol Psychiatry
Publisher Elsevier
Specialty Psychiatry
Date 1993 Feb 15
PMID 8097114
Citations 122
Authors
Affiliations
Soon will be listed here.
Abstract

The relationship between central D2-dopamine receptor occupancy and antipsychotic drug effects was examined in a double-blind study. Raclopride was the compound used to induce a selective occupancy of the D2-dopamine receptors. In addition, 11C-labeled raclopride was the radioligand used to measure occupancy by positron emission tomography (PET). Seventeen schizophrenic patients were randomly assigned to one of three parallel groups treated for 4 weeks with daily doses of 2, 6, or 12 mg of raclopride. D2-receptor occupancy was determined by PET at steady-state conditions in 13 patients who completed the study. A statistically significant relationship was demonstrated between antipsychotic effect and degree of D2-receptor occupancy (p < 0.05). Patients with extrapyramidal side effects had significantly higher D2-receptor occupancy than those without (p = 0.02). The finding of a relationship between selective occupancy of the D2-dopamine receptors and clinical effects in schizophrenic patients principally provides new support for the dopamine hypothesis of antipsychotic drug action.

Citing Articles

Handwriting Kinematics in Patients with Schizophrenia Treated with Long-Acting Injectable Atypical Antipsychotics: Results From the ALPINE Study.

Caligiuri M, Weiden P, Legedza A, Yagoda S, Claxton A Schizophr Bull Open. 2024; 3(1):sgac018.

PMID: 39144789 PMC: 11205961. DOI: 10.1093/schizbullopen/sgac018.


Exploring causal mechanisms of psychosis risk.

Oliver D, Chesney E, Cullen A, Davies C, Englund A, Gifford G Neurosci Biobehav Rev. 2024; 162:105699.

PMID: 38710421 PMC: 11250118. DOI: 10.1016/j.neubiorev.2024.105699.


Does Slow and Steady Win the Race? Rates of Antipsychotic Discontinuation, Antipsychotic Dose, and Risk of Psychotic Relapse.

McCutcheon R, Taylor D, Rubio J, Nour J, Pillinger T, Murray R Schizophr Bull. 2023; 50(3):513-520.

PMID: 37797288 PMC: 11059789. DOI: 10.1093/schbul/sbad139.


Blood-Based MicroRNAs in Psychotic Disorders-A Systematic Review.

Grosu S, Dobre M, Milanesi E, Hinescu M Biomedicines. 2023; 11(9).

PMID: 37760977 PMC: 10525934. DOI: 10.3390/biomedicines11092536.


Insights into the Mechanism of Action of Antipsychotic Drugs Derived from Animal Models: Standard of Care versus Novel Targets.

Grace A, Uliana D Int J Mol Sci. 2023; 24(15).

PMID: 37569748 PMC: 10418544. DOI: 10.3390/ijms241512374.